Smallpox

Second vaccine study begins in Oakland, California

Published in Vaccine Weekly, November 27th, 2002

At the Oakland Medical Center, volunteer adults between 32 and 70 years old were revaccinated against smallpox in a study that will test the effectiveness of different dilutions of smallpox vaccine.

Kaiser Permanente's Vaccine Study Center is the lead center in a consortium evaluating the effectiveness of the vaccines on adults who were inoculated against smallpox as children more than 3 decades ago.

Vaccine Study Center Codirector Dr. Steve Black leads the research at the Oakland site in a consortium which also includes Stanford University Medical Center in Palo Alto, California.

"Our earlier trial this past summer showed that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-11-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry